None
Quote | Evotec SE (NYSE:EVO)
Last: | $ |
---|---|
Change Percent: | 0.08% |
Open: | $12.61 |
Close: | $12.62 |
High: | $12.62 |
Low: | $12.55 |
Volume: | 19,443 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Evotec SE (NYSE:EVO)
2024-05-02 09:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Growth stocks have been huge winners over the past 18 months. Investors have shrugged off the sector’s 2022 bust and returned to growth and technology names with great enthusiasm. ...
2024-05-01 01:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Evotec SE (NYSE:EVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EVTCY News Article - Evotec Launches 'BeLAB2122', Translating Academic Innovation from | whytestocks | investorshangout | 04/13/2021 3:40:53 PM |
whytestocks: $EVTCY News Article - Evotec, Sensyne Health, The University Of Oxford, OSI, and OUI Cr | whytestocks | investorshangout | 06/24/2019 1:35:40 PM |
Emylers: EVTCY Financials Monday, July 14, 2014 10:38:01 PM Evotec AG EVTCY is either non-reporting | Emylers | investorshangout | 07/15/2014 2:38:03 AM |
Stock_Tracker: Latest Evotec Ag Ads (EVTCY) Headlines Will Johnson & Johnson's New Alzheimer's Partn | Stock_Tracker | investorshangout | 03/09/2014 11:23:23 PM |
chartguy89: EVTCY 11.18 Stock Charts $EVTCY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 9:01:57 AM |
News, Short Squeeze, Breakout and More Instantly...
Evotec SE Company Name:
EVO Stock Symbol:
NYSE Market:
2024-05-01 01:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS JOINT EFFORT AIMS TO DEVELOP INNOVATIVE THERAPIES IN PRECISION CARDIOLOGY BERLIN A...